Review
The aging brain, a key target for the future: The protein kinase C involvement

https://doi.org/10.1016/j.phrs.2007.04.013Get rights and content

Abstract

The brain represents the primary centre for the regulation and control of all our body activities, receiving and interpreting sensory impulses and transmitting information to the periphery. Most importantly, it is also the seat of consciousness, thought, emotion and especially memory, being in fact able to encode, store and recall any information. Memory is really what makes possible so many of our complex cognitive functions, including communication and learning, and surely without memory, life would lose all of its glamour and purpose. Age-associated mental impairment can range in severity from forgetfulness at the border with pathology to dementia, such as in Alzheimer's disease. In recent years, one of the most relevant observations of research on brain aging relates to data indicating that age-related cognitive decline is not only due to neuronal loss, as previously thought; instead, scientists now believe that age-associated functional changes have more to do with the dysfunctions occurring over time. Within this context a prominent role is certainly played by signal transduction cascades which guarantee neuronal cell to elaborate coordinated responses to the multiple signals coming from the outside and to adapt itself to the environmental changes and requests. This review will focus the attention on protein kinase C pathway, with a particular interest on its activation process, and on the role of protein–lipid and protein–protein interactions to selectively localize the cellular responses. Furthermore, information is emerging and will be discussed on the possibility of mRNA stabilization through PKC activation. This review will also approach the issue on how alterations of these molecular cascades may have implications in physiological and pathological brain aging, such as Alzheimer's disease.

Introduction

In recent years science and technology have made big steps, allowing us to greatly improve knowledge in basically every aspect of biology, culminating in the mapping of the human genome. However, although the brain is considered our most vital organ, the essence of personality and memory, much about the human brain still remains a mystery. Up to the second half of the 80s, neuroscientists thought that the brain was inexorably losing neurons with age, ultimately leading to serious cognitive deficits. In fact, morphological analyses seemed to support the idea that senescence was accompanied by neuronal loss, particularly evident in the cortical and hippocampal structures [1]. The remaining neurons compensated this deficit through an increased dendritic sprouting, at least until the degeneration did not exceed a certain threshold [2]. However, investigations based on stereological techniques, suggested that neuronal loss was much less important than what was previously believed [3]. Within this context, the finding that old rats, showing a reduced performance in the Morris maze spatial task, do not present any hippocampal (the hippocampus is the brain area mainly implicated in spatial orientation) neurodegeneration [4] further supports the concept that the cognitive decline that occurs with normal aging may be rather due to functional changes, such as those involving cell-to-cell communication and signal transduction mechanisms [5], [6]. Along with this idea, a growing number of observations indicates that age-associated alterations involve a broad spectrum of neurotransmitter systems and their related signalling pathways [7], [8], [9], [10]. Overall, these changes are responsible for an altered interneuronal communication that can represent, rather than morphological modifications, the primum movens leading to cognitive decline. Considering that protein kinases play a strategic role aimed to convert the extracellular signals into biological responses, it is logic to hypothesize that functional alterations on kinases may directly contribute to age-dependent neuronal dysfunctions. At brain level, among the different protein kinases, and especially for its key involvement in memory processes, a great interest has always been addressed to protein kinase C (PKC).

Section snippets

Diversity

Several specific extracellular signals target selected cell surface receptors leading to the hydrolysis of membrane phospholipids via Phospholipase C activation with the generation of two second messengers: diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). IP3 triggers the subsequent release of calcium (Ca2+) from the intracellular store—the endoplasmic reticulum. Ca2+ and DAG are implicated in the activation of a specific family of kinases named protein kinases C.

The

Aspects within the PKC activation pathway: anchoring proteins

As previously mentioned, the interaction of PKC with its physiological stimulators allows the activation of the enzyme. The redistribution/translocation of PKC from one to another subcellular compartment was initially thought to reflect only the interaction between PKC and lipids. However, studies on trypsin sensitivity underlined the implication also of anchoring proteins within this process, indicating the additional relevance of protein–protein interactions in the PKC activation cascade [23]

Emerging aspects within the PKC activation pathway: ELAV proteins

Long lasting changes occurring in selected cellular domains are often the result of protein synthesis reprograms that ultimately lead to modifications in the content of a given gene product and the related protein, via events affecting nuclear transcription and/or the fate of the transcribed mRNAs. Within this context, post-transcriptional processes, and in particular mRNA decay modulation, are emerging as key controllers of gene expression (reviewed in: [39], [40], [41]) and are documented to

PKC and neuronal rescue/survival

A variety of neuronal pathologies are described in which PKC or selected isoforms may be involved or being one of the relevant players, such as in acute (cerebral ischemia and trauma), or chronic (amyotrophic lateral sclerosis, Parkinson and Alzheimer's disease) neurodegeneration (see Ref. [50] for a review). Although, as already discussed, neuronal loss is not a prerequisite in physiological aging, in pathological aging neurodegeneration is a central player. Early loss of PKC is a fundamental

The aging-associated memory impairment: PKC as a key actor

Generally speaking, learning and memory mechanisms are complex and dynamic processes encompassing the encoding, storage, and retrieval of diverse types of information that affect the biochemistry and physiology of specific brain regions, the strength and the morphology of multiple synapses, ultimately leading to persistent changes that alter the efficacy of cell-to-cell communication (see Ref. [58]). Several investigations have documented the critical role of PKC in memory [59], [60], [61], [62]

Pathological aging and PKC: the example of Alzheimer's disease

Dementia can especially be considered as an impairment of memory and other cognitive abilities, which are sufficient to interfere with normal daily activities. Dementia may be inexorably progressive, such as that caused by Alzheimer's disease (AD), the most common form of dementia and also the most dramatic manifestation of cognitive decline in the elderly. Typically, AD leads to an insidious impairment of recent memory, and progressively affects language, personality, and most other aspects of

Interventions on PKC signalling in physiological and pathological aging

Is it possible to counteract the age-related loss of PKC activation? Various conditions known to recover age-related functional deficits are reported to involve PKC signalling. The first observations reported are indirect data relating PKC activation to age-dependent changes. For instance, exogenous phosphatidylserine given chronically (17 days) to aged animals can counteract the impaired hippocampal depolarization-dependent (and PKC-mediated) phosphorylation of the GAP-43 protein [86].

Conclusions

Brain science is making tremendous progress to better understand what happens to memory and other cognitive functions as we age. Signal transduction can be considered the official translator of the cells, allowing each cell to understand in its own language the stimuli arriving from the external environment and thus becoming able to elaborate the adequate outputs. Within this context, it is logical to think that age-related changes occurring in cell-to-cell communication may be extremely

Acknowledgements

The authors would like to thank Annamaria Pascale-Proksch for carefully reviewing the manuscript and Dr. Miriam Duchen for her precious and constant support. Part of these studies was supported by a grant from Italian Ministero Sanità/Regione Lazio (Progetto Alzheimer) to F.B.

References (94)

  • E.H. Sklan et al.

    RACK1 has the nerve to act: structure meets function in the nervous system

    Prog Neurobiol

    (2006)
  • B.L. Smith et al.

    Inhibition of protein kinase C function by injection of intracellular receptor for the enzyme

    Biochem Biophys Res Commun

    (1992)
  • D. Ron et al.

    C2 region-derived peptides inhibit translocation and function of beta protein kinase C in vivo

    J Biol Chem

    (1995)
  • D. Ron et al.

    Coordinated movement of RACK1 with activated betaII PKC

    J Biol Chem

    (1999)
  • D. Schechtman et al.

    Isozyme-specific inhibitors and activators of protein kinase C

    Methods Enzymol

    (2002)
  • H.B. Osborne

    An insight into the post-transcriptional control of gene expression in cell function

    Biol Cell

    (2003)
  • M. Kracht et al.

    Transcriptional and post-transcriptional control of gene expression in inflammation

    Cytokine

    (2002)
  • J. Shim et al.

    The control of mRNA stability in response to extracellular stimuli

    Mol Cells

    (2002)
  • A.B. Sachs

    Messenger RNA degradation in eukaryotes

    Cell

    (1993)
  • M. Amadio et al.

    The different facets of protein kinase C: old and new players in neuronal signal transduction pathways

    Pharmacol Res

    (2006)
  • F. Battaini

    Protein kinase C isoforms as therapeutic targets in nervous system disease states

    Pharmacol Res

    (2001)
  • J. Wang et al.

    Cell-specific role for epsilon- and betaI-protein kinase C isozymes in protecting cortical neurons and astrocytes from ischemia-like injury

    Neuropharmacology

    (2004)
  • S. Mandel et al.

    Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives

    Brain Res Brain Res Rev

    (2005)
  • C. Szabo

    Roles of poly(ADP-ribose) polymerase activation in the pathogenesis of diabetes mellitus and its complications

    Pharmacol Res

    (2005)
  • M. Amadio et al.

    Emerging targets for the pharmacology of learning and memory

    Pharmacol Res

    (2004)
  • J.M. Wehner et al.

    Hippocampal protein kinase C activity is reduced in poor spatial learners

    Brain Res

    (1990)
  • L. Lucchi et al.

    Cognition stimulating drugs modulate protein kinase C activity in cerebral cortex and hippocampus of adult rats

    Life Sci

    (1993)
  • A. Pascale et al.

    Protein kinase C activation and anti-amnesic effect of acetyl-L-carnitine: in vitro and in vivo studies

    Eur J Pharmacol

    (1994)
  • F. Battaini et al.

    Protein kinase C activity, translocation and conventional isoforms in aging rat brain

    Neurobiol Aging

    (1995)
  • E. Sanguino et al.

    Prevention of age-related changes in rat cortex transcription factor activator protein-1 by hypolipidemic drugs

    Biochem Pharmacol

    (2004)
  • M. Racchi et al.

    Rationalizing a pharmacological intervention on the amyloid precursor protein metabolism

    Trends Pharmacol Sci

    (1999)
  • S.L. Gillespie et al.

    Secretory processing of the Alzheimer amyloid beta/A4 protein precursor is increased by protein phosphorylation

    Biochem Biophys Res Commun

    (1992)
  • H.Y. Wang et al.

    Attenuated PKC activity and translocation in Alzheimer's disease brain

    Neurobiol Aging

    (1994)
  • F. Battaini et al.

    Protein kinase C anchoring deficit in postmortem brains of Alzheimer's disease patients

    Exp Neurol

    (1999)
  • C. Gianotti et al.

    B-50/GAP43 phosphorylation in hippocampal slices from aged rats: effects of phosphatidylserine administration

    Neurobiol Aging

    (1993)
  • K.E. Eckles et al.

    Amelioration of age-related deficits in the stimulation of synapsin phosphorylation

    Neurobiol Aging

    (1997)
  • M. Racchi et al.

    Dehydroepiandrosterone and the relationship with aging and memory: a possible link with protein kinase C functional machinery

    Brain Res Brain Res Rev

    (2001)
  • E.G. Stebbins et al.

    Binding specificity for RACK1 resides in the V5 region of beta II protein kinase C

    J Biol Chem

    (2001)
  • D.G. Flood et al.

    Neuron numbers and sizes in aging brain: comparisons of human, monkey, and rodent data

    Neurobiol Aging

    (1988)
  • C. Bertoni-Freddari et al.

    Synaptic structural dynamics and aging

    Gerontology

    (1996)
  • I. Wickelgren

    For the cortex, neuron loss may be less than thought

    Science

    (1996)
  • P.R. Rapp et al.

    Preserved neuron number in the hippocampus of aged rats with spatial learning deficits

    Proc Natl Acad Sci USA

    (1996)
  • M. Gallagher

    Aging and hippocampal/cortical circuits in rodents

    Alzheimer Dis Assoc Disord

    (2003)
  • K.M. Kelly et al.

    The neurobiology of aging

    Epilepsy Res

    (2006)
  • L.F. Agnati et al.

    Cellular and synaptic alterations in the aging brain

    Aging

    (1990)
  • T. Fulop et al.

    Age-related changes in signal transduction

    Drugs Aging

    (1994)
  • K. Yamada et al.

    Changes in NMDA receptor/nitric oxide signaling pathway in the brain with aging

    Microsc Res Tech

    (1998)
  • Cited by (86)

    View all citing articles on Scopus
    View full text